About Index Trending news
Analyze
Pricing
Palatin Technologies

Palatin Technologies

Work at Palatin Technologies? Add yourself to this profile

Palatin Technologies

Palatin Technologies, a biopharmaceutical company, develops targeted receptorspecific peptide therapeutics for the treatment of diseases.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$16,500,000
Employees

Team size

50+
Locations
HQ
Headquarters
$16,500,000 Post-IPO equity
biospace

Palatin Tech Closes On 16 5 Million Financing